MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Stryker Corp

Fermé

SecteurSoins de santé

368.07 -2.53

Résumé

Variation du prix de l'action

24h

Actuel

Min

361.35

Max

377.22

Chiffres clés

By Trading Economics

Revenu

-288M

546M

Ventes

946M

6.4B

P/E

Moyenne du Secteur

48.094

63.778

BPA

4.01

Rendement du dividende

0.9

Marge bénéficiaire

8.484

Employés

53,000

EBITDA

385M

1.8B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+15.32% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.90%

2.39%

Prochains Résultats

29 avr. 2025

Date du Prochain Dividende

30 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8.2B

142B

Ouverture précédente

370.6

Clôture précédente

368.07

Sentiment de l'Actualité

By Acuity

28%

72%

83 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Stryker Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 janv. 2025, 21:55 UTC

Résultats

Stryker Sees Further Organic Sales Growth in 2025

28 janv. 2025, 21:46 UTC

Acquisitions, Fusions, Rachats

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6 janv. 2025, 22:18 UTC

Acquisitions, Fusions, Rachats

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6 janv. 2025, 21:39 UTC

Acquisitions, Fusions, Rachats

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19 févr. 2025, 13:53 UTC

Acquisitions, Fusions, Rachats

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 févr. 2025, 13:30 UTC

Acquisitions, Fusions, Rachats

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 janv. 2025, 21:09 UTC

Acquisitions, Fusions, Rachats

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 janv. 2025, 21:09 UTC

Acquisitions, Fusions, Rachats

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 janv. 2025, 21:08 UTC

Acquisitions, Fusions, Rachats

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 janv. 2025, 21:08 UTC

Acquisitions, Fusions, Rachats

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 janv. 2025, 21:06 UTC

Résultats

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28 janv. 2025, 21:06 UTC

Résultats

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28 janv. 2025, 21:05 UTC

Acquisitions, Fusions, Rachats

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Net $500M >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Adj EPS $4.01 >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Net $546M >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Net $500M >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Sales $6.4B >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q EPS $1.41 >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Adj EPS $4.01 >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q EPS $1.41 >SYK

28 janv. 2025, 21:05 UTC

Résultats

Stryker 4Q Sales $6.4B >SYK

17 janv. 2025, 21:20 UTC

Acquisitions, Fusions, Rachats

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13 janv. 2025, 19:30 UTC

Résultats

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7 janv. 2025, 09:58 UTC

Actions en Tendance

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6 janv. 2025, 22:03 UTC

Actualités
Acquisitions, Fusions, Rachats

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6 janv. 2025, 21:49 UTC

Acquisitions, Fusions, Rachats

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6 janv. 2025, 21:24 UTC

Actualités
Acquisitions, Fusions, Rachats

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6 janv. 2025, 21:11 UTC

Acquisitions, Fusions, Rachats

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6 janv. 2025, 21:10 UTC

Acquisitions, Fusions, Rachats

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Comparaison

Variation de prix

Stryker Corp prévision

Objectif de Prix

By TipRanks

15.32% hausse

Prévisions sur 12 Mois

Moyen 435.3 USD  15.32%

Haut 465 USD

Bas 400 USD

Basé sur 22 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

22 ratings

18

Achat

4

Maintien

0

Vente

Score Technique

By Trading Central

374.61 / 378.05Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Neutral Evidence

Sentiment

By Acuity

83 / 386Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.